About Proinnovera
Proinnovera is a Healthcare company based in Dortmund (Germany) founded in 1997, and was acquired by ARCHIMED in November 2023. Full-service CRO capabilities are offered in over 40 countries. The company has 52 employees. Proinnovera offers products and services including Project Management, Data Management, and Medical Monitoring. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service. Its legal entity is Proinnovera Society for advice, planning and implementation for the development of new pharmaceutical products mbH.
Company details
proinnovera is a full-service global CRO with expertise in therapeutic areas such as dermatology, oncology, and inflammatory diseases. They offer phase I - IV clinical development services for pharma and biotech companies and also for medical device studies. Their services include project management, clinical monitoring, regulatory services, medical writing, clinical development consultancy, quality management, data management and biostatistics, recruitment and feasibility management. Over the last 5 years, they have coordinated over 50 national and international dermatology studies in 344 sites and involving 5362 subjects.
- Headquarters Dortmund, Germany
- Employees 52
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website proinnovera.com
- Social LinkedIn Facebook
- Acquired by ARCHIMED (Nov 2023)
- Legal Name Proinnovera Society For Advice, Planning And Implementation For The Development Of New Pharmaceutical Products Mbh
Products & Services of Proinnovera
Proinnovera offers a comprehensive portfolio of products and services, including Project Management, Data Management, and Medical Monitoring.
Manages clinical trial projects from start to finish.
Handles database design and electronic data capture.
Provides oversight for clinical trial safety and efficacy.
Investors in Proinnovera
Proinnovera has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include ARCHIMED.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare industries are funded and supported globally by ARCHIMED. | archimed.group | Lyon, France |
Investor details for Proinnovera
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Proinnovera
2 dated milestones of Proinnovera across 26 years, from founding to its latest funding, stage changes and deals.
- Founded Proinnovera is founded.
- Exit Acquired by ARCHIMED.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Proinnovera
Complete news archive for Proinnovera
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Proinnovera
Proinnovera was founded in 1997.
Proinnovera is headquartered in Dortmund, Germany. It is registered at Dortmund, North Rhine-westphalia, Germany.
Proinnovera has 52 employees.
proinnovera is a full-service global CRO with expertise in therapeutic areas such as dermatology, oncology, and inflammatory diseases. They offer phase I - IV clinical development services for pharma and biotech companies and also for medical device studies. Their services include project management, clinical monitoring, regulatory services, medical writing, clinical development consultancy, quality management, data management and biostatistics, recruitment and feasibility management. Over the last 5 years, they have coordinated over 50 national and international dermatology studies in 344 sites and involving 5362 subjects.
Proinnovera offers Project Management, Data Management, and Medical Monitoring.
Proinnovera has 1 investor. Key investors include ARCHIMED.
Proinnovera operates through Proinnovera Society For Advice, Planning And Implementation For The Development Of New Pharmaceutical Products Mbh.
Yes. Proinnovera was acquired by ARCHIMED in November 2023.